Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA)

CUSIP: 45826J105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
116,932,531
Total 13F shares
65,174,223
Share change
+778,896
Total reported value
$4,718,129,955
Put/Call ratio
120%
Price per share
$72.67
Number of holders
341
Value change
-$27,349,229
Number of buys
145
Number of sells
198

Quarterly Holders Quick Answers

What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q1 2022

As of 31 Mar 2022, Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) was held by 341 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 65,174,223 shares. The largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., FMR LLC, VIKING GLOBAL INVESTORS LP, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and ALLIANCEBERNSTEIN L.P.. This page lists 341 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.